No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
Metropolis Healthcare Limited, established in Mumbai, India, in 1981, specializes in providing extensive diagnostic services across the nation. The company offers a broad spectrum of clinical laboratory tests, health profiles, and associated support services. Its diagnostic capabilities cover key medical fields such as oncology, neurology, gynecology, and nephrology. Furthermore, Metropolis develops various health assessment packages catering to diverse groups, including men, women, senior citizens, younger individuals, and corporate clients. These tests and profiles are vital for disease prediction, early identification, and accurate diagnosis. Beyond core diagnostics, the company also delivers corporate wellness programs, laboratory solutions for hospitals, and clinical research services.
www.metropolisindia.comNo one on the platform currently holds METROPOLIS.BO.
No tracked institution reports a position in METROPOLIS.BO as of their last filing.
No one on the platform has traded METROPOLIS.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 11.6% | 27.0% | 42.8% | — | — | — |
| Rev. Growth % | 23.6% | 10.5% | ||||
| Profit Margin % | 11.5% | 12.6% | 14.7% | |||
| Free Cash Flow Margin % | 18.2% | 17.3% | 16.7% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $19.0B | +15.3% | $12.37 | $11.98–$13.18 | — | 17 |
| 2028 | $21.8B | +14.8% | $15.59 | $14.65–$17.66 | — | 17 |
| 2029 | $24.7B | +13.2% | $19.29 | $18.32–$21.96 | — | 13 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-04 | $2.68 | $2.70 | +0.7% |
| 2026-05-13 | $2.57 | $2.50 | -2.7% |
| 2026-02-04 | $2.23 | $2.31 | +3.6% |
| 2025-11-04 | $2.73 | $2.55 | -6.6% |
| 2025-08-07 | $2.00 | $2.17 | +8.5% |
| 2025-05-13 | $1.98 | $2.17 | +9.6% |
| 2025-02-04 | $1.79 | $1.53 | -14.5% |
| 2024-11-08 | $2.28 | $2.28 | +0.0% |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| METROPOLIS.BOMetropolis Healthcare Limited | $572.30 | -2.25% | $119.1B | — |
| JLHL.BOJupiter Life Line Hospitals Limited | $275.40 | -1.27% | $91.9B | — |
| JLHL.NSJupiter Life Line Hospitals Limited | $275.55 | -1.29% | $90.3B | — |
| MEDPLUS.BOMedPlus Health Services Limited | $655.25 | -0.81% | $78.7B | — |
| MEDPLUS.NSMedPlus Health Services Limited |
| $656.30 |
| -0.58% |
| $78.8B |
| — |
| PGHL.NSProcter & Gamble Health Limited | $5408.00 | -0.06% | $89.8B | — |
| SHAILY.NSShaily Engineering Plastics Limited | $3181.80 | -2.98% | $146.3B | — |
Source: Financial Modeling Prep · peers by sector/industry